Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Biochemical Reagents >  Agonist Inhibitors >  NPS-1034

NPS-1034

Basic information Safety Supplier Related

NPS-1034 Basic information

Product Name:
NPS-1034
Synonyms:
  • NPS-1034
  • 2-(4-Fluorophenyl)-N-[3-fluoro-4-[(3-phenyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,3-dihydro-1,5-dimethyl-3-oxo-1H-pyrazole-4-carboxamide
  • 1H-Pyrazole-4-carboxamide, 2-(4-fluorophenyl)-N-[3-fluoro-4-[(3-phenyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,3-dihydro-1,5-dimethyl-3-oxo-
  • Mer,NPS-1034,Tyro3,c-Met/HGFR,Apoptosis,Axl,inhibit,TAM Receptor,Inhibitor
  • N-(3-Fluoro-4-((3-phenyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy)phenyl)-2-(4-fluorophenyl)-1,5-dimethyl-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxamide
  • NPS-1034, 10 mM in DMSO
CAS:
1221713-92-3
MF:
C31H23F2N5O3
MW:
551.54
Mol File:
1221713-92-3.mol
More
Less

NPS-1034 Chemical Properties

Density 
1.416±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
Soluble in DMSO
form 
crystalline solid
pka
11.05±0.70(Predicted)
color 
White to off-white
More
Less

NPS-1034 Usage And Synthesis

Uses

NPS-1034 is a dual inhibitor of AXL and MET with IC50s of 10.3 and 48 nM, respectively.

Biological Activity

nps-1034 is a met inhibitor with ic50 of 4 nmol/l [1].the hepatocyte growth factor receptor tyrosine kinase met is required for various morphogenetic events and controls the malignant progression of many human tumors. in various advanced human cancer, gene amplification can deregulate met [1].in mkn45 and snu638 cell lines highly expressing the met gene and p-met (phosphorylated met), ic50 values of nps-1034 to inhibit cell viability were 112.7 and 190.3 nmol, respectively. in ags, katoiii, nci-n87, mkn1, mkn28, and mkn74 cells, the ic50 values of nps-1034 to inhibit cell viability ranged from 1 μmol to more than 10 μmol. in mkn45 cells, treatment with nps-1034 dramatically decreased met phosphorylation (activation). but in mkn28 cells, met phosphorylation was not dramatically decreased. this meant that the anti-proliferative effect of nps-1034 was resulted from its inhibition of p-met [1].in nude mice bearing mkn45 tumors, after the diameter of mkn45 tumors had reached about 180 mm3, nps-1034 at a dose of 30 mg/kg or pbs as vehicle was orally administered once daily for 25 days. it was found that nps-1034 inhibited the proliferation of tumors highly expressing p-met. without drug treatment, neovascularization appeared in tumors in nude mice when the tumor volume was >150 mm3. nps-1034 treatment clearly decreased the vascularization of the tumors in nude mice [1].

in vivo

NPS-1034 inhibits tumor proliferation, which highly expresses p-MET. NPS-1034 treatment induces a clear decrease in the vascularization of the tumors. The expression of alpha-smooth muscle actin (α-SMA) is decreased in the tumor sections of mice treated with NPS-1034. NPS-1034-treated mice show virtually no weight loss, indicating that NPS-1034 is generally well tolerated[2].

IC 50

Axl

References

[1]. shin js, hong sw, moon jh, et al. nps-1034, a novel met inhibitor, inhibits the activated met receptor and its constitutively active mutants. investigational new drugs, 2014, 32(3): 389-399.

NPS-1034Supplier

CEG Chemical Science&Technology Co., Ltd.
Tel
Mobile:13665161512
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185 18149758185;
Email
sales-cpd@caerulumpharma.com
Bide Pharmatech Ltd.
Tel
400-400-164-7117 18317119277
Email
product02@bidepharm.com
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
Shanghai CP Pharmaceutical Technology Co., Ltd.
Tel
18221530285
More
Less

NPS-1034(1221713-92-3)Related Product Information